Small Molecule CRO PharmAgra Labs is a boutique chemistry CRO with an FDA inspected kilo suite, offering cGMP drug substance preparation for Clinical Trials and low volume API manufacturing. This presents a direct sales opportunity to small to mid-size biotech and pharma companies seeking reliable, compliant chemistry support for early-stage to mid-scale drug programs.

Rapid Response Expertise The company emphasizes a rapid-response team of organic chemists across discovery, scale-up, process and analytical chemistry. Target potential clients with urgent timelines or late-stage optimization needs, highlighting the ability to accelerate project timelines and de-risk development bottlenecks.

Diversified Industry Reach PharmAgra serves multiple sectors beyond pharma, including biotechnology, electronics, display technologies, polymers, and medical devices. This suggests cross-industry opportunities for contract chemistry services, particularly for companies requiring custom synthesis, catalysts, or monomer-related chemistry.

Midmarket Revenue Target With reported revenue in the $1M–$10M range and a lean employee base, PharmAgra is positioned to win project-based engagements and volume work from larger CROs or biotech firms seeking cost-effective partnerships, potentially expanding through strategic add-on services or co-development deals.

Global Quality Benchmark An FDA-inspected facility and cGMP capabilities position PharmAgra as a trustworthy partner for quality-critical projects, including clinical trial material. This can be leveraged to approach organizations requiring compliant sourcing, quality assurance, and reliable supply for regulated programs.